Ocular Therapeutix (OCUL) Cash from Operations (2013 - 2026)

Ocular Therapeutix's Cash from Operations history runs 14 years deep, the most recent figure standing at 65993000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 47.73% year-over-year to 65993000.0; the TTM figure through Mar 2026 stood at 226205000.0 (down 55.51% YoY), while the FY2025 annual figure was 204883000.0, down 52.13% from the prior year.
• Cash from Operations was 65993000.0 for Q1 2026 at Ocular Therapeutix, down from 54249000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 7732000.0 in Q3 2023 to a low of 65993000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 31493529.41 across 5 years, with a median of 24802000.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations soared 45.77% in 2022, then plunged 372.83% in 2024.
• A 5-year view of Cash from Operations shows it stood at 16958000.0 in 2022, then plunged by 32.41% to 22454000.0 in 2023, then plunged by 75.6% to 39429000.0 in 2024, then sank by 37.59% to 54249000.0 in 2025, then declined by 21.65% to 65993000.0 in 2026.
• The last three Cash from Operations figures came in at 65993000.0 (Q1 2026), 54249000.0 (Q4 2025), and 50725000.0 (Q3 2025), per Business Quant data.